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180 | Summary 
 
Attention plays a critical role in normal cognitive, emotional and social development. Atten-
tional deficits could affect schooling or vocational education. Attention is, however, a broad 
concept. There are well-defined attentional functions or processes which need to be differenti-
ated. For example, current concepts of attention generally distinguish between selectivity and 
intensity of attention. In addition, a distinction is made between so-called ‘focused attention’, 
‘selective attention’, ‘alertness’, and ‘sustained attention’, whereas deficits in attentional func-
tion are thought to be related to problems in inhibitory processes which are guided by a proper 
functioning of prefrontal areas in the brain. The majority of studies in Attention-
Deficit/Hyperactivity Disorder (ADHD) have shown that children with ADHD have atten-
tional deficits. 
Through the years, psychopharmacological approaches have proven to have beneficial effects 
not only on behavior but also on cognitive functions. Typically, psychotropics like methyl-
phenidate (MPH) are used to improve attentional functions in children and adolescents. How-
ever, the literature is not unambiguous and the precise effects of MPH on cognitive functions 
are less clearly described. There are only a limited number of formal neuropsychological stud-
ies on cognitive deficits in disruptive behavior disorders (DBD) or emotional disorders. Fur-
thermore, hardly any investigations exist on how the typical psychotropic agents actually im-
pact attentional functions in children and adolescents with DBD. This is a serious problem 
due to the high comorbidity between the disorders and possible interaction effects. 
 
Therefore, the aim of this thesis was to learn more about attentional dysfunctions in children 
and adolescents with psychiatric disorders and about the possible influence of psychotropics 
on attentional functions. An improvement in diagnostic processes and an objective tool to 
measure cognitive changes caused by psychotropics may make it possible to improve the effi-
cacy of psychopharmacological treatment. This is why attentional functions in children and 
adolescents with ADHD, ADHD with comorbid DBD, anxiety disorder and depression were 
examined. Furthermore, the thesis investigated how the psychotropic agents typically used for 
the different disorders influenced cognitive functions. 
 
The thesis consists of two parts. Part I (chapters 2 and 3) investigates neuropsychological 
deficits in children with ADHD, ADHD with comorbid DBD, anxiety disorder and depres-
sion. Part II (chapters 4 to 8) examines the influence of various psychopharmacological agents 
(methylphenidate, sertraline and risperidone) on attention, verbal memory and motor activity. 
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Chapter 9 compiles and subsequently discusses the results described in the various chapters of 
the thesis.  
 
Chapter 2 examines verbal memory and aspects of attentional control in children and adoles-
cents with anxiety disorders or depressive disorders. It has been suggested that emotional dis-
orders may be associated with impairments in neurocognitive functioning. However, it still 
remains unclear today whether neurocognitive abilities are disturbed when objective measures 
of attention and memory are applied and, if so, which cognitive impairments are specifically 
associated with either anxiety disorders or depression in childhood. Consequently, chapter 2 
aimed to examine basic performance in attention and memory tasks in treatment-naïve chil-
dren and adolescents with anxiety disorder or depressive disorder under drug-free conditions. 
A total of 34 children between 6 and 17 years of age with an anxiety disorder, 31 children 
with a depressive disorder, and 33 healthy controls were assessed with five different comput-
erized attention tasks and the Auditory-Verbal Learning Test. Chapter 2 provides evidence for 
undisturbed attentional performance in both patient groups and a dissociation in memory 
functioning between anxious and depressed children. Memory impairment was found to be 
specifically associated with childhood depression. 
 
The age differences for impulsivity and sustained attention deficits in ADHD with and with-
out DBD are examined in chapter 3. Attention and executive function deficits are described 
for ADHD and ADHD +DBD. However, it seems that the described deficits are not specific 
to any one clinical group and evidence from research on neuropsychological deficits in 
ADHD or ADHD+DBD is based primarily on children under 12 years of age. Some studies 
suggest that attention and executive function deficits in children with ADHD change with age, 
possibly due to brain development. Therefore, chapter 3 aimed to analyze attention and inhibi-
tion differences between children and adolescents with ADHD and ADHD+DBD. Two age 
groups within each clinical group were compared: children between 8 and 11 years of age and 
adolescents between 12 and 17 years of age. The results indicate that children with ADHD 
have more attentional problems than children with ADHD+DBD and that the ADHD+DBD 
group is more impulsive than the ADHD group. The differences between young ADHD, 
ADHD+DBD and normal controls in the used neuropsychological tasks were not detectable 
with higher age. The performance of adolescents with ADHD+DBD, ADHD or NC is compa-
rable. 
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Chapter 4 examines the age-dependent neuropsychological deficits and effects of MPH in 
children with ADHD. The neuropsychological performance of pre-school and grade-school 
children with ADHD was compared. Attention deficits in both age groups were expected, 
especially in attention intensity and in the inhibitory system. Brain maturation processes 
might result in differences in the distribution of cognitive subtypes across age groups. A sec-
ond aim was to evaluate MPH effects on computerized attention tasks and to compare pre-
school and grade-school children. The pre-school group comprised 45 children aged 5-7 
years; the grade-school group comprised 54 children aged 8-12 years. Children were tested on 
placebo and on MPH, employing tasks of alertness, sustained attention, focused attention, 
divided attention, and a cognitive conflict task. Both groups showed measurable attention 
deficits. While preschoolers were especially impaired in inhibitory functions, grade-schoolers 
most frequently exhibited deficits in attention intensity and selectivity. Positive MPH effects 
were documented for sustained attention in both age groups. Analysis of MPH effects in de-
pendence of the type of attention impairment (supervisory functions vs. attention intensity / 
selectivity) revealed a positive relation between deficits in a specific attention domain and 
MPH effects. Age-dependent differences in attention dysfunctions might be due to brain 
maturational processes.  
 
The focus of chapter 5 is on the differential effects of MPH on attentional functions in chil-
dren with ADHD. Little is known about the sensitivity and specificity of levels of MPH to atten-
tion tasks, and only a limited number of studies are available. Therefore, the aim was to investi-
gate dose-dependent effects on different attentional functions using a theoretically based selection 
of six attention paradigms. A total of 60 ADHD children aged between 8 and 12 years com-
pleted a randomized, double-blind, placebo-controlled, within-subject crossover trial with two 
doses of MPH (0.25 and 0.5 mg/kg body weight) and placebo. A neuropsychological test bat-
tery was applied, including tests of alertness and sustained, focused, and divided attention as 
well as two executive tests, the stop-signal paradigm and a visual set-shifting task. Results in-
dicate that attentional functions are influenced differentially by MPH: intensity functions are 
best influenced by higher doses, executive functions by moderate doses, and selectivity func-
tions by variable doses.  
 
Chapter 6 evaluates the subjective and objective changes in motor activity and attention in 
children with ADHD. Although several studies have examined drug effects on either subjective 
or objective measures of attentional and motor functioning in children with ADHD, little is 
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known about the relationship between these two areas of outcome measures. Studying the 
convergences and divergences of change in these two measures might provide a useful basis 
for optimizing MPH titration guidelines. Therefore, the aim of chapter 6 was to examine 
dose-dependent effects of MPH on motor activity and attention. A total of 44 ADHD children 
with the combined subtype completed a randomized, double-blind, placebo-controlled, crossover 
trial with 2 doses of MPH (0.25; 0.5 mg/kg body weight) and placebo. In each condition, computer-
ized attention tasks were performed, teacher-behavior ratings obtained, and actigraph data col-
lected, in both clinical and natural settings. The results revealed linear effects of MPH dose on 
actigraph data in the test session and at school as well as on sustained attention, while inhibi-
tory control showed a quadratic dose-response curve. Multivariate regression analyses revealed 
that changes of both hyperactive-impulsive symptoms and inattentive symptoms could be ex-
plained by objective changes in motor activity. The results have implications for clinical practice, 
as the behavior ratings of ADHD symptoms appeared to be predominantly influenced by 
changes in motor activity. 
 
Chapter 7 examines the influence of sertraline on attention and verbal memory in children 
and adolescents with anxiety disorders. Several studies demonstrate that sertraline is safe in 
the treatment of children and adolescents. However, their results for SSRI influence on cogni-
tive functions, like attention and memory, remain contradictory. Thus, chapter 7 aims to in-
vestigate the effect of a 6-week course of sertraline treatment on verbal memory and atten-
tional performance in children with anxiety disorders. Children with various anxiety disorders 
(social phobia, generalized and separation anxiety disorder; n=28), aged between 8 and 17 
years, received a standardized computerized neuropsychological assessment before treatment 
and another six weeks after treatment onset with sertraline (daily dose range between 25 and 
100 mg). The patient group was compared to healthy controls (n=28), who were matched for 
age and IQ and were also tested twice over a six-week period. Sertraline did not have any 
negative effects on attentional performance but did increase response speed in a divided atten-
tion paradigm. By contrast, performance in the interference part of a verbal memory task de-
creased. The described results also remained stable over a 12-week period after treatment on-
set. Thus, the cognitive side effects of sertraline seemed to differ slightly between pediatric 
patients and those described in adult patient groups, and should therefore be carefully as-
sessed. 
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The influence of risperidone on attentional functions in children and adolescents with ADHD 
and comorbid DBD is investigated in chapter 8. Risperidone is a well tolerated neuroleptic 
agent and has a place in the management of children with ADHD with associated severe 
DBD, when other treatments have proven unsuccessful. However, little is known about cogni-
tive side effects in ADHD+DPD children with average IQ. Therefore, the study examines the 
influence of risperidone on attentional functions in children with ADHD+DBD with three 
different attention related tasks: (1) a sustained attention task to examine intensity aspects of 
attention; (2) a divided attention task to detect changes in selectivity aspects of attention and 
(3), a Go/No-Go task to examine inhibitory control as a measurement of impulsivity. Risperi-
done-treated children (n=23) with normal IQ and ADHD and severe comorbid DBD were 
compared with an age and IQ matched group of normal controls (n=23). Under risperidone 
medication, children with ADHD+DBD improved on the inattention-overactivity and aggres-
sive behavior scales. No influence of the risperidone medication on the three attention tasks 
could be detected, neither as a positive enhancement nor as adverse side effects. Risperidone 
is useful for treating aggression in children with ADHD with comorbid severe DBD, and it 
has no negative impact on attentional functions. However, additional stimulant treatment 
seems to be necessary to treat the attentional deficits in children with ADHD+DBD. 
 
Chapter 9 gives some concluding remarks on the findings from the experimental research 
described in the thesis and on some implications. The main conclusions of the thesis are: 
• Childhood depression is associated with memory impairment, whereas no attentional per-
formance deficits are detectable for anxiety disorders and depression in pediatric patients. 
• Children with ADHD have more attentional problems than children with ADHD+DBD, 
and children with ADHD+DBD are more impulsive than children with ADHD.  
• The performance of adolescents with ADHD or ADHD+DBD in attention tasks is compa-
rable with that of age and IQ matched normal controls.  
• Children under the age of six with ADHD show deficits in attention control processes, 
whereas older children have problems in the intensity and selective parts of attention. 
• There is no specific difference between MPH effects in pre-school or grade-school children 
with ADHD. 
• MPH significantly improves subjective and objective measures of ADHD symptoms. 
Hyperactivity reduces with dose level, whereas MPH has differential effects on attentional 
functions.  
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• Sertraline induces no deterioration of attentional performance in pediatric patients, 
whereas a negative impact of sertraline on verbal memory is detectable. 
• Risperidone has no influence on attentional functions, neither as a positive enhancement 
nor as an adverse side effect.  
 
Together, these conclusions suggest that in-depth neuropsychological assessment with cognitive 
neuropsychological measures has a major contribution to make to objectively evaluating atten-
tional functions in children and adolescents in a psychiatric setting. For example, behavior rat-
ings of inattentive symptoms are influenced more by objective measures of motor activity 
than by objective measures of attention. This puts into question the typical clinical practice of 
determining the response to stimulant treatment using only subjective measures, such as pa-
rental or teacher ratings. As a consequence, children who are less hyperactive while on MPH 
might be judged as generally improved while they may still suffer from inattentiveness. De-
pending on the predominant attentional deficit of a child, different doses might be necessary to 
improve attentional functions. Thus, it is not enough to examine the efficacy of psychotropic 
treatment with behavioral check lists: it is imperative that objective neuropsychological in-
struments with proven sensitivity, reliability, validity and theoretical background are used. 
The results of lists for behavioral observation are primarily linked to hyperactivity and impul-
sivity and are –generally– not very sensitive. Treatment with higher doses of MPH results in a 
reduction in hyperactive behavior which leads to an overestimation of the attentional func-
tions of the child due to its calm behavior. It is not possible to measure inattention in an ade-
quate manner with these behavioral scales because hyperactivity-impulsivity and inattention 
are two different entities.  
 
 
